Sign in
4

Changes in Ownership

AGIOS PHARMACEUTICALS, INC. Filed Acc 0001439222-20-000024

Chief Financial Officer gave up 1,056 shares (to pay taxes)

  • Chief Financial Officer acquired 3,333 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Hirsch Andrew · Chief Financial Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2020-02-22 Exercise or conversion : show line 1 in the form +3,333 17,574 D
2020-02-24 Shares withheld for taxes : show line 2 in the form −1,056 $48.66 $51,385 16,518 D

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2020-02-22 Exercise or conversion : show line 3 in the form Restricted stock units −3,333 6,667 D
Loading xslF345X03/wf-form4_158266604156652.xml…